Abbott acquires Advanced Medical Optics for $2.8 billion
Clients Abbott Laboratories
Jones Day advised Abbott Laboratories in its $2.8 billion acquisition of Advanced Medical Optics, Inc. (AMO), a manufacturer of ophthalmic care products, comprised of three segments: cataract surgery, laser vision correction (LASIK), and eye care products. The $2.8 billion estimated value of the transaction was based on AMO's approximately 62 million fully diluted shares outstanding, plus estimated net debt at the time of closing. The Boards of Directors of AMO and Abbott have approved the transaction.